SCHEMBL9796207

SCHEMBL9796207

C=CCNS(=O)(=O)c1ccc(C)cc1[N+](=O)[O-]

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
ALDH1A1 P00352 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NFKBIA P25963 2/20 0.46
RELA Q04206 2/20 0.46
KDM4E B2RXH2 2/20 0.46
AGTR1 P30556 1/20 0.46
OPRK1 P41145 1/20 0.46
TSHR P16473 3/20 0.45
MCOLN3 Q8TDD5 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP19A1 P11511 1/20 0.42
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL357662 0.80 CYP19A1 (0.59) ALDH1A1MEN1KMT2ACYP19A1
SCHEMBL9735540 0.78 ALDH1A1 (0.52) CYP3A4CYP1A2CYP2D6ALDH1A1TDP1
SCHEMBL9796198 0.77 ALDH1A1 (0.62) ALDH1A1TDP1MEN1KMT2AKDM4E
SCHEMBL8208785 0.76 MAPK1 (0.44) CYP1A2CYP2D6ALDH1A1TDP1KDM4E
SCHEMBL8415259 0.75 GRIA2 (0.51) CYP3A4CYP1A2ALDH1A1TDP1MEN1
SCHEMBL9796373 0.74 MEN1 (0.50) CYP3A4ALDH1A1TDP1MEN1KMT2A
SCHEMBL14971513 0.74 TSHR (0.45) CYP1A2CYP2D6ALDH1A1TDP1KDM4E
SCHEMBL8597802 0.73 ALDH1A1 (0.47) CYP3A4CYP2D6ALDH1A1MEN1KMT2A
SCHEMBL561968 0.73 NPSR1 (0.62) CYP3A4CYP1A2ALDH1A1MEN1KMT2A
SCHEMBL4067424 0.73 TSHR (0.60) CYP3A4TDP1MEN1KMT2ANFKBIA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4990523-A Treatment of chronic inflammatory joint disease with arylsulfonamides A. H. ROBINS COMPANY, INCORPORATED (US) 1991-02-05 US disclosed
WO-1990015600-A2 TREATMENT OF CHRONIC INFLAMMATORY JOINT DISEASE WITH ARYLSULFONAMIDES A.H. ROBINS COMPANY, INCORPORATED (US) 1990-12-27 WO disclosed